These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 30411297)
1. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway. Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297 [TBL] [Abstract][Full Text] [Related]
2. High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma. Shen CC; Cui XY; He Y; Kang YH; Yi C; Yang JL; Gou LT Pathol Oncol Res; 2015 Apr; 21(2):267-72. PubMed ID: 25079376 [TBL] [Abstract][Full Text] [Related]
3. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
6. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401 [TBL] [Abstract][Full Text] [Related]
7. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. Li B; Yang J; Lu Z; Liu B; Liu F J BUON; 2019; 24(2):739-745. PubMed ID: 31128031 [TBL] [Abstract][Full Text] [Related]
8. STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway. Zhou B; Xiang J; Zhan C; Liu J; Yan S Neuroendocrinology; 2020; 110(3-4):307-320. PubMed ID: 31261148 [TBL] [Abstract][Full Text] [Related]
9. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling. Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Prostate Cancer DU-145 Cells Proliferation by Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576 [TBL] [Abstract][Full Text] [Related]
11. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway. Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839 [TBL] [Abstract][Full Text] [Related]
12. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796 [TBL] [Abstract][Full Text] [Related]
13. Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway. Xue R; Meng Q; Lu D; Liu X; Wang Y; Hao J Oxid Med Cell Longev; 2018; 2018():2798070. PubMed ID: 30046371 [TBL] [Abstract][Full Text] [Related]
14. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis. Zhang Y; Liu JL; Wang J Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426 [TBL] [Abstract][Full Text] [Related]
15. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
18. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. Teng P; Jiao Y; Hao M; Tang X J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322 [TBL] [Abstract][Full Text] [Related]
19. Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K/AKT/mTOR signaling pathway. Li LJ; Chai Y; Guo XJ; Chu SL; Zhang LS Mol Med Rep; 2018 Jun; 17(6):7886-7892. PubMed ID: 29620275 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Xue JF; Shi ZM; Zou J; Li XL Biomed Pharmacother; 2017 May; 89():1252-1261. PubMed ID: 28320092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]